NCT05975112View on ClinicalTrials.gov

The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section

RecruitingOBSERVATIONAL
Enrollment

780

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

April 17, 2025

Conditions
HyperfibrinolysisCesarean Section ComplicationsCoagulation Defect; BleedingPeripartum Haemorrhage
Interventions
DIAGNOSTIC_TEST

Coagulation tests (TEG, Levels of F1, F2, hs-D-dimer, Plasminogen, PAI 1+2), SpHb before discharge

Coagulation tests named earlier as well as SpHb

Trial Locations (1)

8010

RECRUITING

Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER